Add BrightSurf on Google Email

Korea University College of Medicine


Korea University researchers analysis of income-related disparities in mortality among young adults with diabetes

A study published in JAMA Network Open found that young adults with Type 2 diabetes and low income have a significantly higher mortality risk compared to those with high income. The research team analyzed over 600,000 patients and found that patients under 40 with low income had a 2.88 times higher mortality risk.

SourceKorea University College of Medicine·JournalJAMA Network Open·TypeData/statistical analysis·DateFeb 6, 2025

Researchers from Korea University explore how ascorbic acid and FGF4 revolutionize regenerative medicine

Researchers from Korea University have developed a groundbreaking technique to transform fibroblasts into mature cardiomyocytes, holding promise for regenerative medicine in treating cardiovascular disease. The method combines fibroblast growth factor 4 (FGF4) with vitamin C to accelerate cell maturation and enhance function.

SourceKorea University College of Medicine·JournalExperimental & Molecular Medicine·TypeExperimental study·DateDec 24, 2024

Korea University study highlights a novel non-invasive brain surgery for lasting relief from severe obsessive-compulsive disorder

Researchers reported positive long-term results of bilateral capsulotomy for severe obsessive-compulsive disorder treatment, with high patient satisfaction even at 10 years. The study suggests MRgFUS capsulotomy may also be effective in managing other psychiatric diseases.

SourceKorea University College of Medicine·JournalMolecular Psychiatry·TypeRandomized controlled/clinical trial·DateDec 4, 2024

Korea University study links mitochondrial dysfunction to cognitive-metabolic impairments

Researchers created an animal model with a targeted mtDNA mutation to advance understanding of mitochondrial genetic disorders. The study found significant changes in brain structure and function, as well as metabolic abnormalities, linking mitochondrial dysfunction to cognitive-metabolic impairments.

SourceKorea University College of Medicine·JournalExperimental & Molecular Medicine·TypeExperimental study·DateNov 21, 2024

Korea University College of Medicine study reveals COVID-19 vaccine safety in patients with atrial fibrillation/flutter

A Korean University College of Medicine study investigated COVID-19 vaccine safety in patients with atrial fibrillation/flutter. The research found no significant increase in the risk of thromboembolic events following COVID-19 vaccination, but patients without anticoagulant therapy were at higher risk. The study highlights the importa...

SourceKorea University College of Medicine·JournalEuropean Heart Journal·TypeObservational study·DateNov 14, 2024

A joint research team of Korea University College of Medicine announced the world's first single-port robotic thymectomy comparative results

A joint research team at Korea University College of Medicine announced the world's first comparative results of single-port robotic thymectomy, showing a lower conversion rate to multi-port surgery and shorter hospital stays. The study demonstrated that single-port robotic thymectomy is a safer alternative to traditional VATS thymectomy.

SourceKorea University College of Medicine·JournalCancers·TypeExperimental study·DateNov 6, 2024

Korea University study reveals potential effects of uterine artery embolization on subsequent deliveries

A nationwide cohort study revealed a higher risk of placental problems, premature births, and severe bleeding in subsequent deliveries following uterine artery embolization. Babies born to mothers who underwent UAE also had a higher chance of major birth defects, particularly heart problems.

SourceKorea University College of Medicine·JournalHuman Reproduction Open·TypeObservational study·DateSep 20, 2024

Korea University offers new breakthrough for Hepatitis C to improve life expectancy

A new study by Korea University College of Medicine shows that direct-acting antivirals significantly reduce liver-related clinical outcomes and lower the risk of disease progression to cancer or cirrhosis, increasing life expectancy for patients with Hepatitis C. The treatment approach has a high effectiveness rate of 90%.

SourceKorea University College of Medicine·JournalEClinicalMedicine·TypeData/statistical analysis·DateAug 20, 2024

Korea University identifies novel inhibitor HVH-2930 showing promise in overcoming trastuzumab resistance in HER2-positive breast cancer

A novel inhibitor HVH-2930 targeting heat shock protein 90 (HSP90) demonstrates efficacy against drug-resistant breast cancer cells. It selectively downregulates HER2 signaling, crucial for breast cancer progression, without triggering the heat shock response.

SourceKorea University College of Medicine·JournalTheranostics·TypeExperimental study·DateJun 25, 2024

Korea University College of Medicine’s team predict hearing conditions in vestibular schwannoma patients using radiomics

A recent study demonstrates that radiomics can effectively forecast the hearing status of patients with vestibular schwannoma. The research team isolated specific radiomics features from MRI images that best predict hearing status, offering an objective method to predict patient outcomes.

SourceKorea University College of Medicine·JournalEuropean Archives of Oto-Rhino-Laryngology·TypeRandomized controlled/clinical trial·DateMay 31, 2024

Korea University study reveals that gastric cancer surgery may reduce heart disease risk reduced

A Korea University study reveals that gastrectomy decreases the risk of major adverse cardiovascular events in patients with gastric cancer. The research analyzed data from 2004 to 2013 and found a significantly lowered risk of cardiovascular disease in those who underwent gastrectomy.

SourceKorea University College of Medicine·JournalInternational Journal of Surgery·TypeObservational study·DateMay 30, 2024

First detection of hepatitis E virus from urban Norway rats (Rattus norvegicus) in the Republic of Korea

Researchers in South Korea have detected the first hepatitis E virus from urban Norway rats, raising concerns about potential human transmission. The study found that 4.4% of examined rats carried the virus, which is linked to symptoms like fever, fatigue, and jaundice in humans.

SourceKorea University College of Medicine·JournalJournal of Medical Virology·TypeExperimental study·DateMay 10, 2024

Korea University College of Medicine’s team facilitates personalized treatment opportunities for malignant brain tumor, glioblastoma

A team from Korea University College of Medicine has discovered the evolutionary process of glioblastoma recurrence through proteogenomic analysis, providing potential therapeutic avenues. They found that recurrent tumors undergo neuronal transition and BRAF protein kinase activation, leading to resistance to standard treatments.

SourceKorea University College of Medicine·JournalCancer Cell·TypeExperimental study·DateMay 10, 2024

Korea University researchers unveil benefits of perioperative radiotherapy for treating liver cancer with high recurrence risk

Korea University researchers found that perioperative radiotherapy significantly improves survival rates among HCC patients at high risk of recurrence. The study suggests that radiotherapy can reduce recurrence and improve survival in these patients, providing a significant adjuvant treatment option.

SourceKorea University College of Medicine·JournalInternational Journal of Surgery·TypeSystematic review·DateFeb 6, 2024

Research from the Korea University College of Medicine explores the combined health impact of diabetes and sarcopenia in the elderly

A study from the Korea University College of Medicine reveals that co-occurrence of diabetes and sarcopenia significantly elevates cardiovascular mortality, with nearly doubling the risk of both all-cause and cardiovascular deaths. Implementing preventive measures such as lifestyle changes, exercise, and balanced diet can mitigate this...

SourceKorea University College of Medicine·JournalMetabolism·TypeObservational study·DateJan 23, 2024

Korea University and Ewha Womans University researchers highlight advancements in biomedical research with enzyme-activated fluorescent probes

Researchers have summarized recent advances in enzyme-activated near-infrared fluorescent probes for non-invasive visualization of enzyme dynamics and disease status. These probes offer high specificity, sensitivity, and biocompatibility, making them valuable assets in biomedical research and healthcare.

SourceKorea University College of Medicine·JournalTrAC Trends in Analytical Chemistry·TypeLiterature review·DateNov 14, 2023

A comparative analysis of two SARS-CoV-2 vaccines: Insights from Korea University College of Medicine

A recent study published in eClinical Medicine found that the GB510/AS03 vaccine elicited a stronger antibody immune response against the ancestral SARS-CoV-2 strain compared to ChAdOx1-S. The vaccine demonstrated robust safety and efficacy, with no significant safety concerns identified.

SourceKorea University College of Medicine·JournalEClinicalMedicine·TypeRandomized controlled/clinical trial·DateNov 8, 2023

A joint research team from South Korea and the United States has identified a new gene classification system for gastric cancer

A joint research team from South Korea and the US has developed a new genetic classification system for gastric cancer, identifying six consensual genomic subtypes (CGSs) with distinct characteristics. The study suggests potential treatments for each subtype, including immunotherapy and targeted therapies.

SourceKorea University College of Medicine·JournalMolecular Cancer·TypeRandomized controlled/clinical trial·DateNov 6, 2023

Team from Korea University medicine explores ways to overcome cisplatin resistance and alleviate pain in cancer treatment

Researchers from Korea University Medicine have discovered a potential therapeutic target for overcoming cisplatin resistance and neuropathic pain in cervical cancer. By inhibiting TRPV1, they found that resistant tumors became vulnerable to cisplatin, improving the outlook for patients.

SourceKorea University College of Medicine·JournalNature Communications·TypeExperimental study·DateJul 20, 2023